Position in EXEL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$557,570
-$12,220 QoQ
Shares Held
13,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VIRTUS ADVISERS, LLC holds $6,375,075 across 18 Biotechnology names. EXEL ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
42,974 | $956,600 | |
| 2 | GMAB |
Genmab A/S
|
30,830 | $827,168 | |
| 3 | INVA |
Innoviva, Inc.
|
26,946 | $627,841 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
25,800 | $561,408 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
13,000 | $557,570 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,805 | $552,073 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
15,850 | $439,045 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
15,399 | $431,325 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $557,570 | 13,000 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $569,790 | 13,000 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $536,900 | 13,000 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $573,040 | 13,000 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $479,960 | 13,000 | Shares | Other | 2026-02-13 | |
| 2024-12-31 | $330,968 | 9,939 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $389,198 | 14,998 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $337,005 | 14,998 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $387,890 | 16,346 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $335,716 | 13,994 | Shares | Other | 2024-02-15 | |
| 2023-09-30 | $353,991 | 16,201 | Shares | Other | 2023-11-07 | |
| 2023-06-30 | $349,655 | 18,297 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $369,294 | 19,026 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $299,755 | 18,688 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $208,967 | 13,327 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $273,429 | 13,133 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $496,019 | 21,880 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $399,966 | 21,880 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $424,850 | 20,097 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $399,692 | 21,937 | Shares | Other | 2021-08-10 | |
| 2021-03-31 | $687,458 | 30,432 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $594,112 | 29,602 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $638,242 | 26,104 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $567,504 | 23,905 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $568,673 | 33,024 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||